학술논문
An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access
Document Type
Article
Author
Jones, A.V.; Curtiss, D.; Harris, C.; Waheed, N.K.; Southerington, T.; Hautalahti, M.; Wihuri, P.; Mäkelä, J.; Kallionpää, R.E.; Makkonen, E.; Knopp, T.; Mannermaa, A.; Mäkinen, E.; Moilanen, A.-M.; Tezel, T.H.; Arora, R.; Crawford, C.; Creuzot-Garcher, C.; Csaky, K.; Devin, F.; Eichenbaum, D.; Ferrone, P.; Figueroa, M.; Flaxel, C.; Ghorayeb, G.; Gilmour, D.; Grisanti, S.; Guymer, R.; Hall, E.; Heier, J.; Ho, A.; Hoyng, C.; Issa, P.C.; Ivanova, T.; Kaluzny, B.; Khanani, A.; Leveziel, N.; Maturi, R.; McKibbin, M.; Nielsen, J.; Schneiderman, T.; Spitzer, M.; Steele, D.; Suan, E.; Tezel, T.H.; Voleti, V.; Wirthlin, R.
Source
In: PLoS ONE . (PLoS ONE, September 2022, 17 9 September)
Subject
Language
English
ISSN
19326203